Bruker Corp. PT Raised to $22.00 (BRKR)
Analysts at Goldman Sachs Group Inc. increased their price target on shares of Bruker Corp. (NASDAQ:BRKR) from $21.00 to $22.00 in a research report issued to clients and investors on Friday, StockRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Goldman Sachs Group Inc.’s price objective points to a potential upside of 7.11% from the company’s current price.
Bruker Corp. (NASDAQ:BRKR) traded up 1.23% during mid-day trading on Friday, hitting $20.54. The stock had a trading volume of 677,211 shares. Bruker Corp. has a 52 week low of $11.58 and a 52 week high of $21.11. The stock’s 50-day moving average is $20.21 and its 200-day moving average is $18.24. The company has a market cap of $3.426 billion and a price-to-earnings ratio of 42.36.
Bruker Corp. (NASDAQ:BRKR) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.18 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.14 by $0.04. The company had revenue of $454.90 million for the quarter, compared to the consensus estimate of $426.39 million. During the same quarter in the prior year, the company posted $0.12 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. On average, analysts predict that Bruker Corp. will post $0.82 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Maxim Group initiated coverage on shares of Bruker Corp. (NASDAQ:BRKR) in a research note to investors on Thursday. They set a “buy” rating and a $27.00 price target on the stock. Separately, analysts at Cleveland Research initiated coverage on shares of Bruker Corp. (NASDAQ:BRKR) in a research note to investors on Friday, September 20th. They set a “buy” rating on the stock. Finally, analysts at Wells Fargo & Co. downgraded shares of Bruker Corp. (NASDAQ:BRKR) from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, September 20th. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Bruker Corp. currently has an average rating of “Buy” and an average target price of $22.68.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.